Multimorbidität und Polypharmazie und der Einfluss auf die Ernährung
Fischer. K., Battegay, E., Holzer, B.M
Go to publicationFischer. K., Battegay, E., Holzer, B.M
Go to publicationWe conduct interdisciplinary research to support clinical and nonclinical decision makers involved in the management of multimorbid patients.
Go to researchOur research combines the knowledge and perspectives of medical clinicians, data scientists, psychologists, and engineers from biomedicine, computer graphics and computer linguistics.
All membersThe Centre stands alongside a large Department of Internal Medicine, a Preclinical Research Centre, and the Multimorbidity Competence Center.
inneremedizin.usz.ch wagi12.ch multimorbidity.uzh.chWe aim to provide knowledge and tools to aid decision making in multimorbidity management, complexity, uncertainty and risk.
Read moreIndividuals with complex interactions between multiple acute and chronic medical conditions.
20–30% of the Swiss population and ca. 80% of patients in city hospitals are multimorbid.
Multimorbidity can place a very heavy burden on patients, lead to high utilization of health service resources, and generate substantial health care costs.
Depending on the severity and complexity of multiple conditions, a patient's unique combination of diseases and treatment options, benefits and risks needs to be carefully managed.
We have two complementary areas of research that use different data sources and methods.
We apply data scientific methods such as machine learning, visual analytics and medical informatics to healthcare data that is accumulated during healthcare delivery of hospitalized patients.
Go to projectsWe focus on clinical decision-making, risk assessment and communication under real world conditions of complexity, uncertainty and competing demands in the clinical management of multimorbid patients.
Go to projectsThese areas of research enable us to generate clinically meaningful insights and knowledge about multimorbidity and its clinical management from different perspectives. They also provide real world evidence with which to identify opportunities and test ways to improve management of multimorbid patients.
Tatalovic, M., Lehmann, R., Cheetham, M.
2019
Ersözlü, S., Huynh-Do, U., Canaan-Kühl, S., et al.
2018
Battegay, E., und Zeltner, T
2018
Fischer. K., Battegay, E., Holzer, B.M.
2018
Cribari, M., Holzer, B.M., Battegay, E., et al.
2018
Inauen, J., Bierbauer W, Lüscher J, et al.
2017
Battegay E., Cheetham, M.
2017
Siebenhuener, K., Eschmann, E., Kienast, A., et al.
2017
Holzer, B. M., Siebenhuener, K., Bopp, M., & Minder, C. E.
2017
Bierbauer, W., Inauen, J., Schaefer, S., et al.
2017
Battegay E., Cheetham, M., Holzer, B.M., et al.
2017
Lecheler, L., Richter, M., Franzen, D.P., et al.
2017
Gassmann, D., Cheetham, M., Siebenhüner, K., et al.
2017
Holzer, B.M., und Saller, R.
2017
Pereira, A.M., Husmann, L., Sah, B.R., et al.
2016
Siebenhuener, K., Meindl-Fridez, C., Holzer, B.M., et al.
2016
Battegay, E.
2016
Ihle, A., Inauen, J., Scholz, U., et al.
2016
Hausmann, D., Zulian, C., Battegay, E., et al.
2016
Gutermann, I.K., Niggemeier, V., Zimmerli, L.U., et al.
2015
Martin, M., Battegay, E., Röcke, C
2014
Streit, S., da Costa, B.R., Bauer, D.C., et al.
2014
Holzer, B.M., Siebenhuener, K., Bopp, M., et al.
2014
Markun, S., Holzer, B.M., Rodak, R., et al.
2014
Rizza, A., Kaplan, V., Senn, O., et al.
2013
Battegay, E.
2013
Battegay, E.
2013
Schneider, F., Kaplan, V., Rodak, R., et al.
2012